If You Like Eli Lilly, Then You'll Love This Little-Known Specialty Manufacturing Stock
https://www.fool.com/investing/2024/08/24/if-you-like-eli-lilly-then-youll-love-this-little/?source=iedfolrf0000001
Aug 24, 2024 - Jacobs Solutions stands to be a beneficiary of the red-hot weight loss movement fueling the pharmaceutical market.
0
Pharma Stock Roundup: FDA Nod to PFE, MRNA New COVID Jabs & More
https://www.zacks.com/stock/news/2326355/pharma-stock-roundup-fda-nod-to-pfe-mrna-new-covid-jabs-more?cid=CS-ZC-FT-analyst_blog|stock_roundup-2326355
Aug 23, 2024 - LLY's phase III study shows that tirzepatide reduces the risk of developing type II diabetes. FDA approves PFE and MRNA's updated COVID-19 vaccine.
0
How Should You Play Pfizer (PFE) After COVID-Flu Shot Setback?
https://www.zacks.com/stock/news/2324368/how-should-you-play-pfizer-pfe-after-covid-flu-shot-setback?cid=CS-ZC-FT-analyst_blog|most_popular_stocks-2324368
Aug 20, 2024 - After Pfizer's (PFE) better-than-expected second-quarter results and the bullish outlook for the year, investors who own Pfizer's stock may consider staying invested.
0
Walmart Wins Bargain Games
https://www.fool.com/investing/2024/08/19/walmart-wins-bargain-games/?source=iedfolrf0000001
Aug 19, 2024 - The world's largest retailer is crushing the market.
0
Forget Mounjaro: Eli Lilly's Next Big Blockbuster Has Arrived
https://www.fool.com/investing/2024/08/18/forget-mounjaro-eli-lillys-next-big-blockbuster-ha/?source=iedfolrf0000001
Aug 18, 2024 - Eli Lilly has a lot going for it.
0
Prediction: This Hypergrowth Company Could Be the Next Trillion-Dollar Stock
https://www.fool.com/investing/2024/08/18/prediction-this-hypergrowth-company-could-be-the-n/?source=iedfolrf0000001
Aug 18, 2024 - There's no stopping this incredible pharmaceutical stock.
0
Eli Lilly's Top GLP-1 Drugs Now Account for Nearly 40% of Its Revenue, and That's Likely to Go Higher in Future Quarters
https://www.fool.com/investing/2024/08/17/eli-lillys-top-glp-1-drugs-now-account-for-nearly/?source=iedfolrf0000001
Aug 17, 2024 - Mounjaro and Zepbound are likely to be Eli Lilly's top two products in the very near future.
0
Why Lilly (LLY) Might be Well Poised for a Surge
https://www.zacks.com/stock/news/2323318/why-lilly-lly-might-be-well-poised-for-a-surge?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_8-2323318
Aug 16, 2024 - Lilly (LLY) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
0
3 Companies Reporting Remarkable Results: WMT, LLY, CAH
https://www.zacks.com/commentary/2322741/3-companies-reporting-remarkable-results-wmt-lly-cah?cid=CS-ZC-FT-investment_ideas-2322741
Aug 16, 2024 - All three companies posted robust results and upped their outlooks, a bullish pairing. Is it time to buy?
0
Is Eli Lilly (LLY) a Buy Post Stellar Q2 Earnings & Raised View?
https://www.zacks.com/stock/news/2321929/is-eli-lilly-lly-a-buy-post-stellar-q2-earnings-raised-view?cid=CS-ZC-FT-analyst_blog|most_popular_stocks-2321929
Aug 14, 2024 - Eli Lilly (LLY) is a great stock to have in one's portfolio currently based on its strong overall financial performance and robust drug pipeline.
0